Cardiovascular Medical Devices Watch Column
In this new column, Dr Allen Kindman and colleagues will be highlighting ‘hot topics’ in the development and therapeutic use…
Read more
Engagement Shouldn’t Stop at Patients
The clinical technology industry has spent many years working to improve the experience of participating in clinical trials for patients.…
South Africa – A Country Focus
Down at the base of Africa, surrounding land-locked Lesotho, this is a country full of superlatives, amazing heritage, and unique…
Updated Diagnostic Criteria for Parkinson’s Disease: Implications for Clinical Trials
https://www.jforcs.com/7/wp-content/uploads/2016/02/3-J103.pdf
Gene Therapy Clinical Studies in Oncology-Haematology
Gene therapy is no longer the subject of speculative sciencefiction, thanks in part to clinical studies involving gene therapy, which…
Guidance on Submissions for Integrated Summary of Effectiveness
For more than 30 years, the US Food and Drug Administration (FDA) has required sponsors of new drug applications (NDAs)…
Optimising the Design of Dementia with Lewy Bodies Trials
Dementia with Lewy bodies (DLB) is a neurodegenerative disorder characterised by Parkinsonism and cognitive impairment but may also manifest multiple…